MEDICLINIC INTERNATIONAL PLC Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
('Mediclinic', the 'Company'or the 'Group')
5 June 2018
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEMVesting of awards under the Company's Forfeitable Share Plan
Awards of ordinary shares in Mediclinic (the 'Shares') under the Mediclinic International Limited Forfeitable Share Plan ('FSP') granted in June 2015 vested on 1 June 2018.
The table below sets out the number of shares vested for Directors and other persons discharging managerial responsibilities ('PDMRs') who were granted awards under the scheme, together with any disposals made to satisfy their tax liabilities arising on vesting or for other reasons. Mr Danie Meintjes sold the minimum number of shares required to satisfy any tax liability arising on vesting. All shares were sold at a price of ZAR106.91 per Share.
Name | Director/ PDMR | Number of JSE Shares vested | Number of Shares sold | Number of Shares retained |
Danie Meintjes | Director | 33 949 | 15 786 | 18 163 |
David Hadley | PDMR | 7 185 | 7 185 | 0 |
Gert Hattingh | PDMR | 10 094 | 4,693 | 5 401 |
Koert Pretorius | PDMR | 13 241 | 13 241 | 0 |
Dr Dirk le Roux | PDMR | 5 828 | 5 828 | 0 |
Dr Ole Wiesinger1 | PDMR | 12 156 | n/a | n/a |
Notes:
1. Dr Wiesinger was granted a conditional right to 12 156 Shares under the Country Schedule to the Forfeitable Share Plan in June 2015, receivable in cash or Shares on vesting, at Dr Wiesinger's option. On 1 June 2018, Dr Wiesinger elected to receive the equivalent value of the vested shares in cash.
The performance conditions for awards made under the FSP were tested following the change of control in Mediclinic International Limited, resulting from its reverse takeover of Al Noor Hospitals Group Plc. The corresponding awards vested on the original vesting date.
The notifications below are made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.
1. | Details of PDMR / person closely associated with them ('PCA') | |||||
a) | Name | Daniël Petrus Meintjes | ||||
2. | Reason for the notification | |||||
a) | Position / status | Executive Director of the Company | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mediclinic International plc | ||||
b) | LEI | 2138002S5BSBIZTD5I60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 33 949 Nil cost | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Sale of shares vested under the Company's Forfeitable Share Plan to cover tax liabilities arising on vesting | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 15 786 ZAR 106.91 | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
1. | Details of PDMR / person closely associated with them ('PCA') | |||||
a) | Name | David John Hadley | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Executive Officer - Mediclinic Middle East | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mediclinic International plc | ||||
b) | LEI | 2138002S5BSBIZTD5I60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 7 185 Nil cost | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Sale of shares vested under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 7 185 ZAR 106.91 | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
1. | Details of PDMR / person closely associated with them ('PCA') | |||||
a) | Name | Gert Cornelis Hattingh | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Corporate Services Officer of the Mediclinic Group | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mediclinic International plc | ||||
b) | LEI | 2138002S5BSBIZTD5I60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 10 094 Nil cost | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Sale of shares vested under the Company's Forfeitable Share Plan to cover tax liabilities arising on vesting | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 4 693 ZAR 106.91 | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
1. | Details of PDMR / person closely associated with them ('PCA') | |||||
a) | Name | Koert Hendrik Stefanus Pretorius | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Executive Officer - Mediclinic Southern Africa | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mediclinic International plc | ||||
b) | LEI | 2138002S5BSBIZTD5I60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 13 241 ZAR 106.91 | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Sale of shares vested under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 13 241 ZAR 106.91 | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
1. | Details of PDMR / person closely associated with them ('PCA') | |||||
a) | Name | Dr Dirk Cornelius le Roux | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Information Officer of the Mediclinic Group | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mediclinic International plc | ||||
b) | LEI | 2138002S5BSBIZTD5I60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 5 828 Nil cost | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Sale of shares vested under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 5 828 ZAR 106.91 | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
1. | Details of PDMR / person closely associated with them ('PCA') | |||||
a) | Name | Dr Thorsten Ole Wiesinger | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Executive Officer - Hirslanden | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mediclinic International plc | ||||
b) | LEI | 2138002S5BSBIZTD5I60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification Code | Ordinary Shares GB00B8HX8Z88 | ||||
b) | Nature of the transaction | Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | 12 156 Nil cost | ||||
e) | Date of the transaction | 1 June 2018 | ||||
f) | Place of the transaction | Johannesburg Stock Exchange | ||||
About Mediclinic International plc
Mediclinic is an international private healthcare services group with operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group.
Mediclinic comprises 75 hospitals and 28 clinics. Hirslanden operates 17 private acute care facilities and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 22 clinics with more than 700 inpatient beds in the United Arab Emirates.
Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers:Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Attachments
- Original document
- Permalink
Disclaimer
Mediclinic International plc published this content on 05 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 05 June 2018 11:12:04 UTC
